CB1 Receptors: Cocaine Reinforcement and Relapse

CB1 受体:可卡因强化和复发

基本信息

  • 批准号:
    7072354
  • 负责人:
  • 金额:
    $ 5.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The development of genetically altered mice provides a novel way to examine the neurobiological mechanisms underlying both the reinforcing and addictive aspects of drugs of abuse. For example, mice in which the CB1 receptor has been altered can be used to assess the role of these receptors in the reinforcing effects of drugs of abuse. Although well-developed self-administration models exist for examining the reinforcing effects of drugs of abuse in rats, very few self-administration models have been developed for mice and those that do exist have not explored drug self-administration under an extensive range of conditions. Therefore, the current proposal has two goals. One of those goals is to develop drug self-administration procedures in mice that can be used to assess the consequences of prolonged drug exposure on the reinforcing effects of cocaine as well as the process of reinstatement (or relapse) following periods of drug deprivation. The second goal is to employ this set of procedures to assess the role of the CB1 receptor system in cocaine's reinforcing effects and relapse to cocaine seeking.
描述(由申请人提供):基因改变小鼠的开发提供了一种新的方法来检查滥用药物的强化和成瘾方面的神经生物学机制。例如,CB1受体被改变的小鼠可用于评估这些受体在滥用药物的强化作用中的作用。虽然有完善的自我给药模型可用于检查药物滥用对大鼠的强化作用,但很少有为小鼠开发的自我给药模型,而且现有的模型也没有探索在广泛条件下的药物自我给药。因此,目前的建议有两个目标。这些目标之一是开发小鼠自我给药程序,可用于评估长期接触毒品对可卡因强化作用的影响以及在药物剥夺期后恢复(或复发)的过程。第二个目标是采用这套程序来评估CB1受体系统在可卡因的强化作用和可卡因寻求复发中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sara J Ward其他文献

Sara J Ward的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sara J Ward', 18)}}的其他基金

Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    10231167
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    10017870
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    10121270
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    9895145
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    10470743
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Analgesic efficacy of single and combined minor cannabinoids and terpenes
单一和组合次要大麻素和萜烯的镇痛功效
  • 批准号:
    10661039
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
Improved analgesia and safety of CBD over THC or THC+CBD: dose-addition analysis
CBD 比 THC 或 THC CBD 改善镇痛和安全性:剂量添加分析
  • 批准号:
    8701187
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
CB1 Receptors: Cocaine Reinforcement and Relapse
CB1 受体:可卡因强化和复发
  • 批准号:
    6887024
  • 财政年份:
    2005
  • 资助金额:
    $ 5.05万
  • 项目类别:
CB1 Receptors: Cocaine Reinforcement and Relapse
CB1 受体:可卡因强化和复发
  • 批准号:
    7386253
  • 财政年份:
    2005
  • 资助金额:
    $ 5.05万
  • 项目类别:
CB1 Receptors: Cocaine Reinforcement and Relapse
CB1 受体:可卡因强化和复发
  • 批准号:
    7197972
  • 财政年份:
    2005
  • 资助金额:
    $ 5.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了